Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

TADAWUL/4018 stock hub

TADAWUL/4018 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TADAWUL/4018is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.7B

Saudi Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TADAWUL/4018

In the news

Latest news · TADAWUL/4018

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.4

P25 15.3P50 18.4P75 19.8

Trailing P/E24.2

P25 16.2P50 19.4P75 30.1

ROE18.5

P25 9.3P50 15.6P75 21.4

ROIC8.2

P25 7P50 12P75 21

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TADAWUL/4018 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

196

Groups with data

Currency

SAR

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Saudi Arabia
Country code	SA
Employees	2,884
Employees Change	396%
Employees Change Percent	15.92
Enterprise value	SAR 6.5B
Exchange	Saudi Stock Exchange
Financial currency	SAR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	SA1661VHUP11
Last refreshed	2026-05-10
Market cap	SAR 5.7B
Price	SAR 131
Price currency	SAR
Sector	Healthcare
Sic	8060
Symbol	tadawul/4018
Website	https://almoosahealthgroup.org

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.12%
EV Earnings	27.59x
EV/EBIT	29.64x
EV/EBITDA	20.74x
EV/FCF	-22.96x
EV/Sales	4.61x
FCF yield	-4.95%
Forward P/E	18.43x
P/B ratio	2.98x
P/E ratio	24.17x
P/S ratio	4.05x
PEG ratio	0.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.51%
EBITDA Margin	21.54%
Gross margin	29.87%
Gross Profit	SAR 423.1M
Gross Profit Growth	14.87%
Gross Profit Growth Q	-18.67%
Net Income	SAR 236.5M
Net Income Growth	379.28%
Net Income Growth Q	815.29%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	17%
Profit Margin	16.7%
Profitable Years	6
ROA	4.68
Roa5y	3.63
ROCE	7.71
ROE	18.55
Roe5y	12
ROIC	8.19
Roic5y	6.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.45%
EPS Growth	279.9
EPS Growth Q	623.1
EPS Growth Quarters	5
EPS Growth Years	1
OCF Growth	29.47%
Revenue Growth	17.79x
Revenue Growth Q	16.82x
Revenue Growth Quarters	7x
Revenue Growth Years	5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SAR 0.48
Assets	SAR 3.3B
Cash	SAR 80.6M
Current Assets	SAR 799.5M
Current Liabilities	SAR 464.2M
Debt	SAR 870.1M
Debt EBITDA	SAR 2.77
Debt Equity	SAR 0.45
Debt FCF	SAR -3.06
Equity	SAR 1.9B
Interest Coverage	12.1
Liabilities	SAR 1.4B
Long Term Assets	SAR 2.5B
Long Term Liabilities	SAR 924.7M
Net Cash	SAR -789.5M
Net Cash By Market Cap	SAR -13.76
Net Debt EBITDA	SAR 2.59
Net Debt Equity	SAR 0.41
Tangible Book Value	SAR 1.9B
Tangible Book Value Per Share	SAR 43.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.72
Inventory Turnover	13.56
Net Working Capital	SAR 329.4M
Quick ratio	1.5
Working Capital	SAR 335.3M
Working Capital Turnover	SAR 7.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.15%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	SAR 1.4
Dividend Years	2
Dividend Yield	1.07%
Ex Div Date	2026-03-30
Last Dividend	SAR 0.35
Payout Frequency	Quarterly
Payout Ratio	36.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.44%
200-day SMA	163.9
50-day SMA	138.4
50-day SMA vs 200-day SMA	50under200
All Time High	212
All Time High Change	-38.21%
All Time High Date	2025-10-19
All Time Low	126.6
All Time Low Change	3.48%
All Time Low Date	2025-04-07
ATR	3.28
Beta1y	0.18
Beta2y	0.25
Ch YTD	-25.31
High	131.3
High52	212
High52 Date	2025-10-19
High52ch	-38.21%
Low	130.5
Low52	128.3
Low52 Date	2026-03-15
Low52ch	2.1%
Ma50ch	-5.32%
Price vs 200-day SMA	-20.07%
RSI	39.02
RSI Monthly	38.75
RSI Weekly	0
Sharpe ratio	-0.65x
Sortino ratio	-0.69
Total Return	-25.08%
Tr YTD	-25.12
Tr1m	-2.96%
Tr1w	-2.31%
Tr3m	-14.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SAR 219.6M
Operating Income Growth	20.62
Operating Income Growth Q	-20.9
Operating margin	15.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,290,795%
Net Borrowing	-618,513,638
Shares Insiders	0%
Shares Institutions	1.71%
Shares Out	44,303,580
Shares Qo Q	0.39%
Shares Yo Y	26.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SAR -284.3M
Average Volume	38,326.15x
Bv Per Share	43.43
CAPEX	SAR -465.1M
Ch1m	-2.96
Ch1w	-2.31
Ch1y	-21.56
Ch3m	-14.38
Ch6m	-30.69
Change	0.46%
Change From Open	0.38
Close	130.4
Days Gap	0.08
Depreciation Amortization	85,374,374
Dollar Volume	6,128,442
Earnings Date	2026-05-10
EBIT	SAR 219.6M
EBITDA	SAR 305M
EPS	SAR 5.36
F Score	5
FCF	SAR -284.3M
FCF EV Yield	-4.36x
FCF Per Share	SAR -6.42
Financing CF	436,271,484
Fiscal Year End	December
Founded	1,996
Graham Number	72.35771
Graham Upside	-44.77
Income Tax	SAR 4.2M
Investing CF	-617,027,274
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Ma150	161.8
Ma150ch	-19.05%
Ma20	136.7
Ma20ch	-4.14%
Net CF	69,321
Open	130.5
P OCF Ratio	31.73
Payment Date	2026-04-13
Position In Range	62.5
Ppne	2,452,338,930
Price Date	2026-05-07
Price EBITDA	SAR 18.81
Ptbv Ratio	3
Relative Volume	1.22x
Revenue	1,416,284,548x
Tax By Revenue	0.29x
Tax Rate	1.73%
Tr6m	-30.38%
Volume	46,782
Z Score	4.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TADAWUL/4018 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$1.40 annual per share

Payout ratio

+36.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-25.1%

Next ex-dividend date: 2026-03-30

Performance

TADAWUL/4018 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TADAWUL/4018?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.7%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+26.1%

Negative means the company is buying back shares.

Technical

TADAWUL/4018 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.0

Neutral momentum band

Price vs 200-day MA

-20.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TADAWUL/4018

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tadawul/4018 stock rating?

tadawul/4018 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tadawul/4018 analysis?

The full report lives at /stocks/tadawul/4018/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tadawul/4018?

The latest report frames tadawul/4018 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tadawul/4018 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.